Can Remote Monitoring Improve Quality of Care
in Heart Failure Patients with
Implantable Cardioverter Defibrillators?
Background and Significance
Heart failure (HF) patients undergo frequent
visits to clinics and emergency rooms, have
serious clinical implications and are a high
economic burden to society. In the US there
are 400,000 to 700,000 newly diagnosed HF
patients annually.
Remote Monitoring of ICDs can provide
clinicians with early detection of impending
critical clinical issues. Despite the research
data favoring Remote Monitoring,
organizational data is lacking regarding
frequency to assess useful criteria, such as
heart rate trends, activity level, fluid index
and nightly heart rate. It is unclear whether
monthly measurements of these indicators
will result in better clinical outcomes than
quarterly measurements.

Statistical Analysis













 To compare rates between the monthly
remote control group and the quarterly
experimental group for emergency
department and unscheduled clinic visits.
 To evaluate the impact of remote monitoring
as a mechanism to reduce the anxiety level
of patients with an ICD in both the control
and experimental group.

Research Questions
1. Do patients who have an ICD that is
remotely monitored through a wireless
Internet based system on a monthly basis
have a reduced heart failure admission rate
and/or in-office visit as compared to
quarterly face-to-face encounters for device
interrogations?
2. Is there a lower level of anxiety in
patients who have an ICD that was remotely
monitored on a monthly basis for 6 months
as compared to those who receive quarterly
face-to-face encounters for device
interrogations?

Exclusion Criteria:
Pts: awaiting heart transplant,
With left ventricular assist device
Who do not have a landline telephone

Procedure

Based on the financial, logistical and time
constraints, the eligible members for this study was
limited to 35 patients
 The research trial was a comparison study where
the patients were randomly assigned to one of two
groups. This design evaluated the impact of
monthly remote monitoring on heart failure patients
as compared to quarterly face-to-face encounters
for device interrogations.
 Following enrollment, each participant in each group
was provided a set of questionnaires asking about
demographics together with the Beck Anxiety
Inventory questionnaire (BAI). After 6 months, all
participants were requested to retake the BAI.
 The device diagnostics reviewed in the
interrogations in months 1, 2, 3, 4, 5 and 6 or
quarterly were six parameters: the percentage of
ventricular pacing, heart rate variability, average
ventricular heart rate during the evening, the activity
level in hours, the CareLink OptiVol fluid trend, and
the thoracic impedance trend.


Aims of the Study

Inclusion Criteria:
Pts: with BiV-ICDs or ICDs for primary prevention
or secondary prevention
LVEF <35%, age 21 years or older
Speak English with NYHA for HF Class III-IV
Dx of ICM or NICM
Can provide informed consent
Life expectancy greater than 1 year
Have an implanted Medtronic device with software
that can be transmitted wirelessly and have a
landline telephone
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 Descriptive statistics (means ± standard
deviations or medians and interquartile range
[25th percentile, 75th percentile] for continuous
data; frequencies and percentages for
categorical data) were calculated by group
(Monthly Interrogation vs. Quarterly).
 The Fisher’s exact test was used to compare
these two groups for the categorical variables
in the questionnaire. The Mann-Whitney test
was used to compare these two groups for
continuous variables (i.e. Anxiety Pre and
Post).
 Analysis of Covariance (ANCOVA) was used to
test whether there is a difference in anxiety
between the Monthly Interrogation group and
the Quarterly group on the Post-Anxiety scores
while controlling for Pre-Anxiety scores. Since
the pre-score and the post-score are so highly
correlated, the ANCOVA was used to "subtract
out" or "remove” extraneous variability from
the post-scores.

Results

 There were no hospitalizations in the Quarterly
group and there was one subject in the
Monthly interrogation group who had 3
hospitalizations, but the remaining subjects in
that group did not have any hospitalizations.
 There was not a significant difference between
the Monthly Interrogation group and the
Quarterly group with respect to the
categorical variables.
 Post-anxiety score and the Pre-anxiety score
was analyzed separately for each group using
the paired t-test. There was a marginally nonsignificant difference in the Monthly
interrogation group (mean difference = 2.71,
corresponding 95% confidence).
 interval = [-0.025, 5.44], p<0.0519).
 There was not a significant difference between
the two groups across time for Opti Volume
(p<0.0950).
 There was not a significant difference
between the two groups across time for IntraThoracic Imp (p<0.6063
 There was not a significant difference
between the two groups across time for HRV
(p<0.6875).
 There was not a significant difference
between the two groups across time for
Percent Ventricular Pac (p<0.7457).
 There was not a significant difference
between the two groups across time for AVHR
night (p<0.9685).
 There was no significant difference between
the Monthly Interrogation group and the
Quarterly group across time (i.e. group*time
interaction) for Activity (p<0.6082).

Discussion

 Several studies have validated reducing heart
failure progression and readmission for HF by
maximizing pharmacologic intervention. It will
increase quality of life in this population
and potentially be an efficient alternative as
compared to the present standard of quarterly
face-to-face office visits.
 Patients should be educated on RM and also be
informed that RM is a tool to detect early
worsening of heart failure and may improve
clinical management and quality of life.
 Arrhythmia clinics should consider the benefits
of monthly ICD interrogations for both their
patients and the community hospital regardless
of financial reimbursement.
 Remote monitoring may improve overall patient
care and may ultimately reduce health care
costs.

Conclusion

 Monthly RM of ICD devices may be an option for
assessing and improving HF care, reducing
interim visits, and decreasing the anxiety levels
for patients with HF.
 The time duration between remote monitoring
needs to be verified by a large, multicenter,
randomized clinical trial to determine the
clinical potential of more frequent intervals of
RM.
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